| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | $2.27T |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $1.04T | $1.02T | $909.70B | $961.33B | $907.68B |
| R&D | $592.00M | $627.00M | $1.79B | $2.58B | $2.59B |
| SG&A | $387.61B | $366.43B | $320.11B | $310.22B | $280.13B |
| Operating Income | – | – | – | – | $1.07T |
| Interest Expense | $1.69T | $2.15T | – | $2.52T | $1.11T |
| Tax Expense | $207.36B | $219.75B | $97.55B | $93.62B | $221.66B |
| Net Income | $1.04T | $859.85B | $593.84B | $807.48B | $852.43B |
| EPS (basic) | 5.4210 | 4.5260 | 3.0750 | 4.2040 | 4.4870 |
| EPS (diluted) | 5.4210 | 4.5260 | 3.0750 | 4.2040 | 4.4870 |
| Shares (diluted) | $188.45B | $188.45B | $188.45B | $188.45B | $188.45B |